Robert Burns
Stock Analyst at H.C. Wainwright
(4.83)
# 430
Out of 4,408 analysts
1024
Total ratings
47.9%
Success rate
20.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics | Reiterated: Buy | $17 → $23 | $4.08 | +463.73% | 14 | Jun 15, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $32 | $17.04 | +87.79% | 30 | Jun 11, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $27 → $66 | $32.90 | +100.61% | 22 | Jun 10, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $7 | $2.01 | +248.26% | 21 | Jun 8, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $25 | $8.40 | +197.62% | 47 | Jun 8, 2026 | |
| ADCT ADC Therapeutics | Downgraded: Hold | n/a | $1.05 | - | 45 | Jun 8, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $13.61 | +120.43% | 9 | Jun 8, 2026 | |
| RADX Radiopharm Theranostics | Initiated Coverage: Buy | $16 | $4.45 | +259.55% | 1 | Jun 4, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $46 | $23.26 | +97.76% | 42 | Jun 3, 2026 | |
| AKTS Aktis Oncology | Rated: Buy | $33 → $35 | $20.69 | +69.16% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $169 → $195 | $160.06 | +21.83% | 45 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.94 | +342.18% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.42 | - | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $33.17 | +65.81% | 26 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $21.56 | +94.81% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.59 | +52.51% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $14.96 | +87.17% | 35 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.14 | +230.74% | 32 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $1.66 | +562.65% | 29 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.72 | +539.53% | 41 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $8.47 | +136.13% | 15 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $30.30 | +45.21% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $42.36 | +32.20% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $56 | $53.00 | +5.66% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.13 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $13 | $9.64 | +34.85% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $7.73 | +275.16% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $90.80 | +43.17% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $4.46 | +79.57% | 23 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.85 | +237.66% | 6 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.11 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.94 | +467.01% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $8.96 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $27 | $8.13 | +232.31% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $27 | $4.20 | +542.86% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.50 | +433.33% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.27 | +340.53% | 7 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.06 | +371.70% | 21 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.98 | - | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.85 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4687 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.1621 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.272 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.86 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.54 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.04 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.67 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.92 | n/a | 8 | Mar 5, 2021 |
Elicio Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: $17 → $23
Current: $4.08
Upside: +463.73%
Nurix Therapeutics
Jun 11, 2026
Reiterated: Buy
Price Target: $32
Current: $17.04
Upside: +87.79%
Tango Therapeutics
Jun 10, 2026
Reiterated: Buy
Price Target: $27 → $66
Current: $32.90
Upside: +100.61%
Fate Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.01
Upside: +248.26%
ORIC Pharmaceuticals
Jun 8, 2026
Reiterated: Buy
Price Target: $25
Current: $8.40
Upside: +197.62%
ADC Therapeutics
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.05
Upside: -
Cullinan Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $30
Current: $13.61
Upside: +120.43%
Radiopharm Theranostics
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.45
Upside: +259.55%
Zymeworks
Jun 3, 2026
Reiterated: Buy
Price Target: $46
Current: $23.26
Upside: +97.76%
Aktis Oncology
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $20.69
Upside: +69.16%
Jun 2, 2026
Reiterated: Buy
Price Target: $169 → $195
Current: $160.06
Upside: +21.83%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $2.94
Upside: +342.18%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.42
Upside: -
Jun 1, 2026
Reiterated: Buy
Price Target: $55
Current: $33.17
Upside: +65.81%
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $21.56
Upside: +94.81%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $4.59
Upside: +52.51%
May 26, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $14.96
Upside: +87.17%
May 26, 2026
Reiterated: Buy
Price Target: $17
Current: $5.14
Upside: +230.74%
May 26, 2026
Maintained: Buy
Price Target: $11
Current: $1.66
Upside: +562.65%
May 22, 2026
Reiterated: Buy
Price Target: $11
Current: $1.72
Upside: +539.53%
May 22, 2026
Reiterated: Buy
Price Target: $15 → $20
Current: $8.47
Upside: +136.13%
May 12, 2026
Reiterated: Buy
Price Target: $44
Current: $30.30
Upside: +45.21%
May 11, 2026
Reiterated: Buy
Price Target: $56
Current: $42.36
Upside: +32.20%
May 7, 2026
Reiterated: Buy
Price Target: $54 → $56
Current: $53.00
Upside: +5.66%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.13
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $8 → $13
Current: $9.64
Upside: +34.85%
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $7.73
Upside: +275.16%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $90.80
Upside: +43.17%
Apr 27, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $4.46
Upside: +79.57%
Apr 22, 2026
Reiterated: Buy
Price Target: $13
Current: $3.85
Upside: +237.66%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.11
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.94
Upside: +467.01%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $8.96
Upside: -
Mar 23, 2026
Reiterated: Buy
Price Target: $50 → $27
Current: $8.13
Upside: +232.31%
Mar 16, 2026
Maintained: Buy
Price Target: $34 → $27
Current: $4.20
Upside: +542.86%
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.50
Upside: +433.33%
Feb 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.27
Upside: +340.53%
Nov 12, 2025
Reiterated: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.98
Upside: -
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $13.85
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.4687
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.1621
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.272
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $29.86
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $5.54
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.04
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.67
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.92
Upside: n/a